APGE
Apogee Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Largest filed tie
0
filed ties
Fund move
Fund move
−0.14%
vs ±0.6% implied · ×0.23
shaded = implied · ▲▼ = realized
No thesis.
Apogee Therapeutics, Inc.
135.07
−0.01 · 0.00%
post 135.10 +0.02%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | VR AdviserVR Adviser | $1.1B | 12.31% | 0.00% | |
| 2 | BlackRockBlackRockindex-like | $730.9M | 7.98% | +34.79% | |
| 3 | HBK Investments L PHBK Investments L P | $378.3M | 4.13% | new | |
| 4 | Vanguard Capital ManagementVanguardindex-like | $341.4M | 3.73% | +2.80% | |
| 5 | FMRFMR | $330.9M | 3.61% | −73.08% | |
| 6 | State StreetState Streetindex-like | $305.0M | 3.33% | +6.23% | |
| 7 | Balyasny Asset ManagementBalyasny | $287.4M | 3.14% | +393.58% | |
| 8 | Driehaus Capital ManagementDriehaus | $231.0M | 2.52% | −9.41% | |
| 9 | Goldman Sachs GroupGoldman Sachs | $224.8M | 2.45% | +159.48% | |
| 10 | Glazer CapitalGlazer Capital | $217.8M | 2.38% | new | |
| 11 | Paradigm Biocapital AdvisorsParadigm Biocapital | $209.2M | 2.28% | +16.92% | |
| 12 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $202.9M | 2.22% | +285.73% | |
| 13 | Millennium ManagementMillennium | $199.3M | 2.18% | +1521.63% | |
| 14 | Pentwater Capital ManagementPentwater | $189.1M | 2.07% | new | |
| 15 | Morgan StanleyMorgan Stanley | $188.7M | 2.06% | +138.93% | |
| 16 | Geode Capital ManagementGeodeindex-like | $174.6M | 1.91% | +8.02% | |
| 17 | Perceptive AdvisorsPerceptive | $173.6M | 1.90% | −15.08% | |
| 18 | Jupiter TopcoJupiter Topco | $158.4M | 1.73% | — | |
| 19 | Bank of AmericaBank of America | $149.5M | 1.63% | +25.01% | |
| 20 | Affinity Asset AdvisorsAffinity Asset | $131.0M | 1.43% | −23.19% | |
| 21 | Mercer Global Advisors Inc /advMercer Global Advisors Inc /adv | $124.9M | 1.36% | +13.21% | |
| 22 | First Light Asset ManagementFirst Light | $123.5M | 1.35% | +61.32% | |
| 23 | AlliancebernsteinAlliancebernstein | $102.9M | 1.12% | −21.73% | |
| 24 | T. Rowe Price Investment ManagementT. Rowe Price | $101.2M | 1.10% | −92.60% | |
| 25 | Kryger CapitalKryger Capital | $98.6M | 1.08% | new |
291 managers report $9.2B of Apogee Therapeutics on form 13F for the quarter ended Jun 30 '26. 38 of them hold 80% of it; VR Adviser is largest at 12.31%.
No implied move.
No implied move.
Expected move
No implied move.